These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15206694)

  • 1. An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis.
    Salo H; Pekurinen M; Granlund H; Nuutinen M; Erkko P; Reitamo S
    Acta Derm Venereol; 2004; 84(2):138-41. PubMed ID: 15206694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis.
    Granlund H; Erkko P; Remitz A; Langeland T; Helsing P; Nuutinen M; Reitamo S
    Acta Derm Venereol; 2001; 81(1):22-7. PubMed ID: 11411908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: two paired-comparison studies.
    Jekler J; Larkö O
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):151-6. PubMed ID: 1814425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototherapy of atopic dermatitis with ultraviolet radiation.
    Jekler J
    Acta Derm Venereol Suppl (Stockh); 1992; 171():1-37. PubMed ID: 1585754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-light therapies in atopic dermatitis.
    Falk ES
    Photodermatol; 1985 Aug; 2(4):241-6. PubMed ID: 3903678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy.
    Brazzelli V; Prestinari F; Chiesa MG; Borroni RG; Ardigò M; Borroni G
    Dermatology; 2002; 204(3):252-4. PubMed ID: 12037459
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study.
    Jekler J; Larkö O
    J Am Acad Dermatol; 1990 Jan; 22(1):49-53. PubMed ID: 2298965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications.
    Schiffner R; Schiffner-Rohe J; Gerstenhauer M; Hofstädter F; Landthaler M; Stolz W
    Br J Dermatol; 2001 Jun; 144(6):1154-60. PubMed ID: 11422035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography.
    Osmola-Mańkowska A; Polańska A; Silny W; Żaba R; Adamski Z; Dańczak-Pazdrowska A
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3927-34. PubMed ID: 25555886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phototherapy in the management of atopic dermatitis: a systematic review.
    Meduri NB; Vandergriff T; Rasmussen H; Jacobe H
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):106-12. PubMed ID: 17598862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis.
    Legat FJ; Hofer A; Brabek E; Quehenberger F; Kerl H; Wolf P
    Arch Dermatol; 2003 Feb; 139(2):223-4. PubMed ID: 12588233
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin maintenance therapy for severe atopic dermatitis.
    Korstanje MJ; van de Staak WJ
    Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of childhood atopic dermatitis in a multi-ethnic Asian population: a cost-of-illness study.
    Olsson M; Bajpai R; Wee LWY; Yew YW; Koh MJA; Thng S; Car J; Järbrink K
    Br J Dermatol; 2020 May; 182(5):1245-1252. PubMed ID: 31420964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics of drug therapy for atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2002 Mar; 3(3):249-55. PubMed ID: 11866675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Maintenance Treatment with a Barrier-strengthening Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden.
    Norrlid H; Hjalte F; Lundqvist A; Svensson Å; Tennvall GR
    Acta Derm Venereol; 2016 Feb; 96(2):173-6. PubMed ID: 26304099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin treatment of atopic dermatitis: five case studies and literature review.
    Stephens RB; Lee ML; Cooper A
    Australas J Dermatol; 1994; 35(2):55-9. PubMed ID: 7702488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.